A detailed history of Trexquant Investment LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Trexquant Investment LP holds 2,550 shares of LLY stock, worth $1.99 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,550
Holding current value
$1.99 Million
% of portfolio
0.03%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $1.97 Million - $2.45 Million
2,550 New
2,550 $2.26 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $3.14 Million - $4.32 Million
7,213 New
7,213 $3.87 Million
Q2 2022

Aug 11, 2022

SELL
$278.73 - $327.27 $6.17 Million - $7.24 Million
-22,131 Reduced 77.1%
6,574 $2.13 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $1.95 Million - $2.42 Million
-8,313 Reduced 22.46%
28,705 $8.22 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $1.85 Million - $2.3 Million
8,244 Added 28.65%
37,018 $10.2 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $6.38 Million - $7.85 Million
28,774 New
28,774 $6.65 Million
Q1 2021

May 13, 2021

SELL
$164.32 - $212.72 $2.74 Million - $3.55 Million
-16,668 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$130.46 - $172.63 $2.72 Million - $3.6 Million
-20,829 Reduced 55.55%
16,668 $2.81 Million
Q3 2020

Nov 06, 2020

BUY
$146.22 - $169.13 $1.48 Million - $1.71 Million
10,135 Added 37.04%
37,497 $5.55 Million
Q2 2020

Aug 07, 2020

BUY
$136.42 - $164.18 $1.52 Million - $1.83 Million
11,141 Added 68.68%
27,362 $4.49 Million
Q1 2020

May 08, 2020

BUY
$119.05 - $147.35 $1.93 Million - $2.39 Million
16,221 New
16,221 $2.25 Million
Q3 2019

Nov 08, 2019

SELL
$106.79 - $116.16 $1.81 Million - $1.97 Million
-16,957 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$110.79 - $129.32 $1.88 Million - $2.19 Million
16,957 New
16,957 $1.88 Million
Q1 2019

May 13, 2019

SELL
$111.31 - $131.02 $1.32 Million - $1.55 Million
-11,842 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $504,931 - $565,675
4,768 Added 67.4%
11,842 $1.37 Million
Q3 2018

Nov 09, 2018

BUY
$85.86 - $107.31 $607,373 - $759,110
7,074 New
7,074 $759,000
Q1 2018

May 03, 2018

SELL
$74.21 - $87.6 $420,770 - $496,691
-5,670 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$81.94 - $87.89 $464,599 - $498,336
5,670
5,670 $479,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.